- Topic1/3
49k Popularity
35k Popularity
51k Popularity
9k Popularity
23k Popularity
- Pin
- 🎉 The #CandyDrop Futures Challenge is live — join now to share a 6 BTC prize pool!
📢 Post your futures trading experience on Gate Square with the event hashtag — $25 × 20 rewards are waiting!
🎁 $500 in futures trial vouchers up for grabs — 20 standout posts will win!
📅 Event Period: August 1, 2025, 15:00 – August 15, 2025, 19:00 (UTC+8)
👉 Event Link: https://www.gate.com/candy-drop/detail/BTC-98
Dare to trade. Dare to win.
- 🎉 Gate Square Growth Points Summer Lucky Draw Round 1️⃣ 2️⃣ Is Live!
🎁 Prize pool over $10,000! Win Huawei Mate Tri-fold Phone, F1 Red Bull Racing Car Model, exclusive Gate merch, popular tokens & more!
Try your luck now 👉 https://www.gate.com/activities/pointprize?now_period=12
How to earn Growth Points fast?
1️⃣ Go to [Square], tap the icon next to your avatar to enter [Community Center]
2️⃣ Complete daily tasks like posting, commenting, liking, and chatting to earn points
100% chance to win — prizes guaranteed! Come and draw now!
Event ends: August 9, 16:00 UTC
More details: https://www
Hang Likang: Currently, there is only one innovative drug project under research.
Jin10 Data July 1st, Anglikon released an announcement regarding abnormal fluctuations in stock trading. The company has noticed that the market's attention on innovative drug business has been relatively high recently. Currently, the company has only one innovative drug project under research, which is the ALK-N001 project. This project received a notice of approval for clinical trials in April 2025, and as of the date of this announcement, it is still in the Phase I clinical trial stage. The development of innovative drugs is characterized by long cycles, high investment, and high uncertainty, and investors are advised to pay attention to investment risks.